All News, Video and Posts related to TOPIC: Earnings

Thursday, June 26, 2008

CNBC.com's News Now: GM Shares at 53-Year Low

CNBC News Now  
DOW 11453.42 alt -358.41 -3.03%  
NASDAQ 2321.37 s -79.89 -3.33%
S&P 500 1283.15 alt -38.82 -2.94%
 
NEWS MARKETS EARNINGS INVESTING VIDEO CNBC TV CNBC Plus
Untold Wealth Premieres Tonight 10p/1a ET
  Thursday, Jun. 26, 2008

 
 
TODAY'S TOP 5
Video 1 1. Goldman Deals a Blow to Brokers

Video 2 2. GM Shares at 53-Year Low

Video 3 3. Stop Trading, Listen to Cramer!

Video 4 4. The $42M Spec House

Video 5 5. NYSE Market Wrap

 


 

  Click here to view all the Top Stories
 

Investing Tools

alt Portfolio Watchlist

Insider Trends

Financial Glossary

Stock Screeners

Fund Screeners

Earnings Screeners 
alt
Click here for more

CNBC Blogspot
CNBC Bloggers

Credit Suisse Healthier 15: Investors Get Skinny On Fat Fighters

Credit Suisse is out today with a "fat" report on obesity. Nearly 200 pages. But besides its size, the research also stands out as one of the most unique pieces of Wall Street analysis I've ever seen. Click here to read more.

CNBC Blogwatch
 

 
Tune In to CNBC Tomorrow!

GATES' LAST DAY **EXCLUSIVE**: On the day that Bill Gates hangs it up as the day-to-day Microsoft chief, NBC's Tom Brokaw talks to the living legend about his tenure at the top.

MICROSOFT AFTER GATES: Bill Gates has been the defining face of business in the Internet age. As he checks out, Jim looks at how Microsoft will move on and what can be done to break the stock out of the trading range it's been stuck in for more than six years. Is Steve Ballmer the right man to head the software giant? How will Microsoft's strategy change without Gates in the mix?

DRIVE FOR THE BORDER: Many Americans who live near the border and finding that there's a very good reason to make the trek down South: cheap gas. Gas is subsidized by the government in Mexico, and the enormous cost savings are drawing Americans in droves and causing shortages throughout Baja California. Jane Wells takes a road trip.

MERCK ON MIGRAINES: Mike Huckman is following the release of late-stage data on Merck's key migraine drug. The results are pivotal for the company's advance in a multibillion dollar niche. And as one of the worst performers of the Dow this year, Merck could certainly use a dose of good news.

 
Watch CNBC LIVE on your computer - CNBC Plus
CNBC First in Business Worldwide

To unsubscribe to this email click here
If this e-mail was forwarded to you and you would like to subscribe to CNBC.com's News Now mailing, please click here


No comments:

Blog Archive